Cytokine antibody array analysis in brain and periphery of scrapie-infected Tg338 mice

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 34, Issue 5, 2011, Pages 387-397

  Newsom, Denise M ^a   Liggitt, H Denny ^a   O'Rourke, Katherine ^b   Zhuang, Dongyue ^b   Schneider, David A ^b   Harrington, Robert D ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Cytokine; Prion; Scrapie; TIMP 1

Indexed keywords

CD30 ANTIGEN; CD40 ANTIGEN; COLONY STIMULATING FACTOR 1; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; L SELECTIN; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 5; PADGEM PROTEIN; RANTES; STROMAL CELL DERIVED FACTOR 1ALPHA; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CLINICAL FEATURE; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOASSAY; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SCRAPIE; SERUM; SPLEEN;

ANIMALS; ANTIBODIES; BIOLOGICAL MARKERS; BLOTTING, WESTERN; BRAIN; DISEASE PROGRESSION; GLIOSIS; INTERLEUKIN-10; LYMPH NODES; MICE; MICE, TRANSGENIC; PRIONS; SCRAPIE; SHEEP; SPLEEN; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

ANIMALIA; BOVINAE; CAPRA HIRCUS; MUS; OVIS ARIES;

EID: 80052918138     PISSN: 01479571     EISSN: 18781667     Source Type: Journal    
DOI: 10.1016/j.cimid.2011.06.001     Document Type: Article

References (35)

1. Gajduskek D.C. Unconventional viruses and the origin and disappearance of kuru. Science 1977, 197:943-960.
2. Schneider K., Fangerau H., Michaelsen B., Raab W.H. The early history of transmissible spongiform encephalopathies exemplified by scrapie. Brain Res Bull 2008, 77:343-355.
3. Prusiner S.B. Molecular biology of prion diseases. Science 1991, 252:1515-1522.
4. Soto C. Prions: the new biology of proteins 1991, CRC Press, Boca Raton.
5. Riemer C., Gültner S., Heise I., Holtkamp N., Baier M. Neuroinflammation in prion diseases: concepts and targets for therapeutic intervention. CNS Neurol Disord Drug Targets 2009, 8:329-341.
6. McFarlin D.E., Raff M.C., Simpson E., Nehlsen S.H. Scrapie in immunologically deficient mice. Nature 1971, 233:336.
7. Campbell I.L., Eddleston M., Kemper P., Oldstone M.B.A., Hobbs M.V. Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie. J Virol 1994, 68:2383-2387.
8. Williams A.E., van Dam A.-M., Man-A-Hing W.K.H., Berkenbosch F., Eikelenboom P., Fraser H. Cytokines, prostaglandins and lipocortin-1 are present in the brains of scrapie-infected mice. Brain Res 1994, 654:200-206.
9. Brown A.R., Webb J., Rebus S., Walker R., Williams A., Fazakerley J.K. Inducible cytokine gene expression in the brain in the ME7/CV mouse model of scrapie is highly restricted, is at a strinkingly low level relative to the degree of gliosis and occurs only late in disease. J Gen Virol 2003, 84:2605-2611.
10. Riemer C., Neidhold S., Burwinkel M., Schwarz A., Schultz J., Krätzschmar J., et al. Gene expression profiling of scrapie-infected brain tissue. Biochem Biophys Res Commun 2004, 323:556-564.
11. Gu Q. High-throughput identification of molecular targets of brain disorders using antibody-based microarray analyses. Expert Rev Neurother 2008, 8:1281-1283.
12. Le Dur A., Béringue V., Andréoletti O., Reine F., Laï T.L., Baron T., et al. A newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes. Proc Natl Acad Sci U S A 2005, 102:16031-16036.
13. Vilotte J.L., Soulier S., Essalmani R., Stinnakre M.G., Vaiman D., Lepourry L., et al. Markedly increased susceptibility to natural sheep scrapie of transgenic mice expressing ovine PrP. J Virol 2001, 75:5977-5984.
14. O'Rourke K.I., Baszler T.V., Besser T.E., Miller J.M., Cutlip R.C., Wells G.A., et al. Preclinical diagnosis of scrapie by immunohistochemistry of third eyelid lymphoid tissue. J Clin Microbiol 2000, 38:3254-3259.
15. Safar J., Wille H., Itri V., Groth D., Serban H., Torchia M., et al. Eight prion strains have PrPSc molecules with different conformations. Nat Med 1998, 4:1157-1165.
16. Spraker T.R., Balachandran A., Zhuang D., O'Rourke K.I. Variable patterns of distribution of PrPCWD in the obex and cranial lympoid tissues of Rock Mountain elk (Cervus elaphus nelsoni) with subclinical chronic wasting disease. Vet Rec 2004, 155:295-302.
17. Schulz-Schaeffer W.J., Fatzer R., Vandevelde M., Kretzschmar H.A. Detection of PrP(Sc) in subclinical BSE with the paraffin-embedded tissue (PET) blot. Arch Virol 2000, Suppl:173-180.
18. Schulz-Schaeffer W.J., Tschoke S., Kranefuss N., Drose W., Hause-Reitner D., Giese A., et al. The paraffin-embedded tissue blot detects PrPSC early in the incubation time in prion diseases. Am J Pathol 2000, 156:51-56.
19. Abramoff M.D., Magelhaes P.J., Ram S.J. Image processing with ImageJ. Biophotonics Int 2004, 11:36-42.
20. Bolea R., Monleón E., Schiller I., Raeber A.J., Acín C., Monzón M., et al. Comparison of immunohistochemistry and rapid tests for detection of abnormal prion protein in different brain regions of sheep with typical scrapie. J Vet Diagn Invest 2005, 17:467-469.
21. Moore S.J., Simmons M., Chaplin M., Spiropoulos J. Neuroanatomical distribution of abnormal prion protein in naturally occurring atypical scrapie cases in Great Britain. Acta Neuropathol 2008, 116:547-559.
22. Bruce M.E., Boyle A., McConnell I. TSE strain typing in mice. Techniques in prion research (methods and tools in biosciences and medicine) 2004, 132-146. Birkhaüser Verlag, Switzerland. S. Lehmann, J. Grassi (Eds.).
23. Harrington R.D., Baszler T.V., O'Rourke K.I., Schneider D.A., Spraker T.R., Liggitt H.D., et al. A species barrier limits transmission of chronic wasting disease to mink (Mustela vison). J Gen Virol 2008, 89:1086-1096.
24. Lu Z.Y., Baker C.A., Manuelidis L. New molecular markers of early and progressive CJD brain infection. J Cell Biochem 2004, 93:644-652.
25. Koedel U., Merbt U.M., Schmidt C., Angele B., Popp B., Hermann W., et al. Acute brain injury triggers MyD88-dependent, TLR2/4-independent inflammatory responses. Am J Pathol 2007, 171:200-213.
26. Thackray A.M., Hopkins L., Klein M.A., Bujdoso R. Mouse-adapted ovine scrapie prion strains are characterized by different conformers of PrPSc. J Virol 2007, 81:12119-12127.
27. Romero-Trevejo J.L., Gómez-Villamandos J.C., Pedrera M., Blanco A., Bautista M.J., Sánchez-Cordón P.J. Immunohistochemical study of macrophage and cytokine dynamics in the gut of scrapie-infected mice. Histol Histopathol 2010, 25:1025-1038.
28. Cunningham C., Wilcockson D.C., Boche D., Perry V.H. Comparison of inflammatory and acute-phase responses in the brain and peripheral organs of ME7 model of prion disease. J Virol 2005, 79:5174-5184.
29. Tribouillard-Tanvier D., Striebel J.F., Peterson K.E., Chesebro B. Analysis of protein levels of 24 cytokines in scrapie-infected brain and glial cell cultures of mice differing in prion protein expression. J Virol 2009, 83:11244-11253.
30. Brown A.R., Webb J., Rebus S., Walker R., Williams A., Fazakerley J.K. Inducible cytokine gene expression in the brain in the ME7/CV mouse model of scrapie is highly restricted, is at a strikingly low level relative to the degree of gliosis and occurs only late in disease. J Gen Virol 2003, 84:2605-2611.
31. Hernández-Guillamon M., Delgado P., Ortega L., Pares M., Rosell A., García-Bonilla L., et al. Neuronal Timp-1 release accompanies astrocytic MMP-9 secretion and enhances astrocyte proliferation induced by β-amyloid 25-35 fragment. J Neurosci Res 2009, 87:2115-2125.
32. Nuttall R.K., Silva C., Hader W., Bar-Or A., Patel K.D., Edwards D.R., et al. Metalloproteinases are enriched in microglia compared with leukocytes and they regulate cytokine levels in activated microglia. Glia 2007, 55:516-526.
33. Beuche W., Yushchenko M., Mäder M., Maliszewska M., Felgenhauer K., Weber F. Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis. Neuroreport 2000, 11:3419-3422.
34. Dominguez-Villar M., Hafler D.A. An innate role for IL-17. Science 2011, 332:47-48.
35. Kawanokuchi J., Shimizu K., Nitta A., Yamada K., Mizuno T., Takeuchi H., et al. Production and functions of IL-17 in microglia. J Neuroimmunol 2008, 194:54-61.